Traveler's diarrhea: updates for pediatricians.
暂无分享,去创建一个
[1] C. Bartley,et al. Osmotic demyelination syndrome following rapid correction of hyponatraemia , 2007, Anaesthesia.
[2] B. Kligler,et al. Probiotics in children. , 2007, Pediatric clinics of North America.
[3] G. Glenn,et al. Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch , 2007, Expert review of vaccines.
[4] H. Szajewska,et al. Systematic review: racecadotril in the treatment of acute diarrhoea in children , 2007, Alimentary pharmacology & therapeutics.
[5] H. Dupont,et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] L. Mcfarland. Meta-analysis of probiotics for the prevention of traveler's diarrhea. , 2007, Travel medicine and infectious disease.
[7] M. Curran,et al. Nitazoxanide , 2012, Drugs.
[8] D. Diemert. Prevention and Self-Treatment of Traveler's Diarrhea , 2006, Clinical Microbiology Reviews.
[9] J. Gascón. Epidemiology, Etiology and Pathophysiology of Traveler’s Diarrhea , 2006, Digestion.
[10] Johnnie A Yates,et al. Reiter's syndrome (reactive arthritis) and travelers' diarrhea. , 2006, Journal of travel medicine.
[11] A. Keenum,et al. Rifaximin (Xifaxan) for traveler's diarrhea. , 2005, American family physician.
[12] B. Connor. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] H. Dupont,et al. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] R. Steffen. Epidemiology of traveler's diarrhea. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Mackell. Traveler's diarrhea in the pediatric population: etiology and impact. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] A. M. Ahmed,et al. Genomic analysis of a multidrug-resistant strain of enterohaemorrhagic Escherichia coli O157:H7 causing a family outbreak in Japan. , 2005, Journal of medical microbiology.
[17] J. Dale. Oral rehydration solutions in the management of acute gastroenteritis among children. , 2004, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.
[18] D. Milewicz,et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. , 2003, The Journal of infectious diseases.
[19] R. Kato,et al. Prevalence of Escherichia coli possessing the eaeA gene of enteropathogenic E. coli (EPEC) or the aggR gene of enteroaggregative E. coli (EAggEC) in traveler's diarrhea diagnosed in those returning to Tama, Tokyo from other Asian countries. , 2002, Japanese journal of infectious diseases.
[20] Z. Jiang,et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] S. Monday,et al. Genetic Analysis for Virulence Factors inEscherichia coli O104:H21 That Was Implicated in an Outbreak of Hemorrhagic Colitis , 2001, Journal of Clinical Microbiology.
[22] B. Lowe,et al. In Vitro Antimicrobial Susceptibility Testing of Bacterial Enteropathogens Causing Traveler's Diarrhea in Four Geographic Regions , 2001, Antimicrobial Agents and Chemotherapy.
[23] I. Potasman,et al. Inflammatory bowel disease in returning travelers. , 2006, Journal of travel medicine.
[24] R. V. von Vigier,et al. Acute community-acquired diarrhea requiring hospital admission in Swiss children. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] F. Cobelens. Yellow fever vaccination and risk of spontaneous abortion , 1998, Tropical medicine & international health : TM & IH.
[26] C. Ericsson,et al. TRAVELERS' DIARRHEA: Epidemiology, Prevention, and Self-Treatment , 1998 .
[27] N. Rollins,et al. Surgical lessons learned from the Shigella dysenteriae type I epidemic. , 1998, Journal of the Royal College of Surgeons of Edinburgh.
[28] C. Hoge,et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. , 1996, JAMA.
[29] H. Dupont,et al. Persistent diarrhea in travelers. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] C. Hoge,et al. Prevalence of Cyclospora species and other enteric pathogens among children less than 5 years of age in Nepal , 1995, Journal of clinical microbiology.
[31] Peltola,et al. Risk Behavior for Travelers' Diarrhea Among Finnish Travelers. , 1995, Journal of travel medicine.
[32] H. Dupont,et al. Prevention and treatment of traveler's diarrhea. , 1993, The New England journal of medicine.
[33] R. Steffen,et al. Incidence and clinical features of traveler's diarrhea in infants and children. , 1991, The Pediatric infectious disease journal.
[34] R. Steffen,et al. 'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? , 1985, International journal of epidemiology.
[35] J. Mendiola,et al. Furazolidone versus ampicillin in the treatment of traveler's diarrhea , 1984, Antimicrobial Agents and Chemotherapy.
[36] R. Steffen,et al. Epidemiology of diarrhea in travelers. , 1983, JAMA.
[37] H. Dupont,et al. Adverse effect of lomotil therapy in shigellosis. , 1973, JAMA.